Find more info and the full series here: [ Ссылка ]

DNA vaccines are based on plasmid DNA that can be produced at a large scale in bacteria and contain expression promoters and the gene that encodes the spike protein. The advantage of these technologies is the possibility of large-scale production as well as the high stability of plasmid DNA.

This is a snapshot of emerging vaccines during a rapidly evolving pandemic. Any and all information currently available related to COVID-19 is subject to change as more details become available.

This article originally appeared on Univadis, part of the Medscape Professional Network.

свернуть